The aim of this study was to determine the effects of folate deficiency and supplementation on AD-like pathology in APP/PS1 mice when daily treatment begun at seven months of age, when visible Aβ deposition may begin to be detected in this mouse model. This evidence concerns the gene APP and Alzheimer disease.